These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8049652)

  • 1. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
    Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
    Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.
    Cogswell PC; Morgan R; Dunn M; Neubauer A; Nelson P; Poland-Johnston NK; Sandberg AA; Liu E
    Blood; 1989 Dec; 74(8):2629-33. PubMed ID: 2684296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
    Gaiger A; Henn T; Hörth E; Geissler K; Mitterbauer G; Maier-Dobersberger T; Greinix H; Mannhalter C; Haas OA; Lechner K; Lion T
    Blood; 1995 Sep; 86(6):2371-8. PubMed ID: 7662984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
    Martinelli G; Zaccaria A; Farabegoli P; Buzzi M; Testoni N; Bragliani M; Panzica G; Tura S
    Leuk Lymphoma; 1993; 11 Suppl 1():51-6. PubMed ID: 8251917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
    Rooke HM; Vitas MR; Crosier PS; Crosier KE
    Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
    J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
    Li Z; Luo J
    Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.
    Okabe M; Kunieda Y; Nakane S; Kurosawa M; Itaya T; Vogler WR; Shoji M; Miyazaki T
    Leuk Lymphoma; 1995 Feb; 16(5-6):493-503. PubMed ID: 7787756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
    Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP
    Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
    LeMaistre A; Lee MS; Talpaz M; Kantarjian HM; Freireich EJ; Deisseroth AB; Trujillo JM; Stass SA
    Blood; 1989 Mar; 73(4):889-91. PubMed ID: 2645949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan.
    Tien HF; Chuang SM; Wang CH; Lee FY; Chien SH; Chen YC; Shen MC; Liu CH
    Cancer Genet Cytogenet; 1989 May; 39(1):89-97. PubMed ID: 2731152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelocytic leukemia with myeloblastoma has higher frequency of ras oncogene mutation.
    Tanaka K; Takauchi K; Takechi M; Dohy H; Kamada N
    Leuk Res; 1992 Sep; 16(9):947. PubMed ID: 1405725
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia.
    Spencer A; Vulliamy T; Kaeda J; Goldman JM; Melo JV
    Leukemia; 1997 Feb; 11(2):195-201. PubMed ID: 9009080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia.
    Gow J; Hughes D; Farr C; Hamblin T; Oscier D; Brown R; Padua RA
    Leuk Res; 1988; 12(10):805-10. PubMed ID: 3059070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
    Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.